3SBIO: Next Day Disclosure Return
3SBIO: Next Day Disclosure Return
3SBIO: PROPOSED SHARE REPURCHASE
3SBIO: FINAL DIVIDEND FOR THE YEAR ENDED 31 DECEMBER 2023
3SBIO: NOTIFICATION LETTER AND REPLY FORM TO NON-REGISTERED SHAREHOLDERS - ARRANGEMENT OF ELECTRONIC DISSEMINATION OF CORPORATE COMMUNICATIONS
3SBIO: NOTIFICATION LETTER AND REPLY FORM TO REGISTERED SHAREHOLDERS - ARRANGEMENT OF ELECTRONIC DISSEMINATION OF CORPORATE COMMUNICATIONS
3SBIO: Monthly Return of Equity Issuer on Movements in Securities for the month ended 29 February 2024
3SBIO: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2024
3SBIO: VOLUNTARY ANNOUNCEMENT - MANDI FOAM OF 3SBIO APPROVED FOR MARKET LAUNCH
3SBIO: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2023
3SBIO: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2023
3SBIO: VOLUNTARY ANNOUNCEMENT OF 3SBIO INC. -3SBIO INC.HAS ENTERED INTO LICENSING AGREEMENT WITH CSTONE PHARMACEUTICALS IN RESPECT OF ANTI-PD-1 MONOCLONAL ANTIBODY NOFAZINLIMAB
3SBIO: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2023
3SBIO: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2023
3SBIO: Notification Letter to Non-registered Holders and Request Form
3SBIO: Notification Letter to Registered Shareholders and Change Request Form
3SBIO: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2023
3SBIO: Next Day Disclosure Return
3SBIO: WITHDRAWAL OF LISTING OF ZERO COUPON CONVERTIBLE BONDS DUE 2025
3SBIO: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2023
No Data